|
|
Title:
Delivery vehicle for probiotic bacteria comprising a dry matrix of
polysaccharides, saccharides and polyols in a glass form and methods of
making same
United States Patent: 8,097,245
Issued: January 17, 2012
Inventors: Harel; Mordechi
(Baltimore, MD), Kohavi-Beck; Keren (Kfar Aviv, IL)
Assignee: Advanced
Bionutrition Corporation (Columbia, MD)
Appl. No.: 12/159,407
Filed: December 28, 2006
PCT Filed: December 28,
2006
PCT No.: PCT/US2006/049434
371(c)(1),(2),(4) Date: November
21, 2008
PCT Pub. No.: WO2007/079147
PCT Pub. Date: July 12,
2007
|
|
|
Outsourcing Guide
|
Abstract
The disclosure relates to a solid glass
matrix of polysaccharide, saccharides and polyols as delivery vehicle for
preservation and post gastric administration of a probiotic. The delivery
vehicle is capable of releasing the probiotic at their site of action. The
present invention further includes methods of making and using the solid
glass matrix delivery vehicle of the invention.
Description of the
Invention
BACKGROUND OF THE DISCLOSURE
The disclosure relates generally to the field of a delivery vehicle for
probiotic bacteria comprising a dry matrix of polysaccharides, saccharides
and polyols in a glass form. Methods of making and uses thereof are also
provided.
Probiotics are defined as live microbes that beneficially affect the host
by modulating mucosal and systemic immunity, as well as improving
intestinal function and microbial balance in the intestinal tract. Various
nutritional and therapeutic effects have been ascribed to probiotics
including: modulating immune response, lowering serum cholesterol
concentrations, improving lactose intolerance symptoms, increasing
resistance to infectious intestinal diseases, decreasing duration of
diarrhea, reducing blood pressure, and helping to prevent colon cancer (Isolauri
E et al. 2001, Kailasapathy K and J. 2000, Marteau PR et al. 2001,
Perdigon G et al. 2001). In order to exert their beneficial effects on the
host, probiotics must remain viable and reach the intestine in large
numbers (Favaro-Trindade and Grosso 2002). However, maintaining long term
stability of probiotics requires special storage conditions, since
viability deteriorates rapidly over a short time period at ambient
temperature and humid conditions (Shah 2000). In addition to poor shelf
life, a significant loss of viability occurs upon exposure of the
probiotics to gastric conditions of low pH and digestive enzymes. Existing
preservation methods fail to provide satisfactory viability upon storage
and gastric protection, especially if cells are stored at ambient or
higher temperature and humidity.
Freeze-drying is often used for preservation and storage of bacteria
because of the low temperature exposure during drying. However, it has the
undesirable characteristics of significantly reducing viability as well as
being time and energy-intensive. Freeze-drying involves placing the cells
in solution, freezing the solution, and exposing the frozen solid to a
vacuum under conditions wherein it remains solid and the water and any
other volatile components are removed by sublimation. Standard freeze
drying temperature of -30.degree. C. to -70.degree. C. are below the
freezing point of water, but are well above the glass transition (Tg)
temperature of the drying solution, which results in the undesirable
effect of crystallization of water into ice. Freezing bacterial cultures
results in substantial physical damage to the bacterial cell wall and
subsequent loss of viability. Therefore, avoiding ice formation during
cold storage of proteins, viruses, cells, tissues, and organs is an
important problem in cryobiology.
The freezing point of water can be lowered by adding solutes that lower
the vapor pressure of water. Freezing point depression is the physical
basis on which essentially all currently used antifreeze agents (e.g.,
glycols, sugars and salts) perform. The disadvantage of freezing point
depressors, known as cryoprotectants, is that large quantities of solutes
(10% or more) are required to lower the freezing point by even a few
degrees Celsius. At sufficiently high concentrations (typically 50% or
more), conventional antifreeze agents can prevent ice formation, allowing
aqueous solutions to be cooled to temperatures well below 0.degree. C.
without freezing. However, cryoprotectants are generally toxic at the high
concentrations required to achieve glass formation or vitrification.
Other methods used to prepare dry and stable preparations of probiotics
such as desiccation at ambient temperature and spray drying also has
drawbacks. Desiccation at low or ambient temperature is slow, requires
extra precautions to avoid contamination, and often yields unsatisfactory
viability. Spray drying involves short excursions to relatively high
processing temperatures and results in viability losses and limited
storage times, even when stabilizing excipients are used (Lievense L C,
van't Riet K. 1994. Convective drying of bacteria. II. Factors influencing
survival. Adv Biochem Eng Biotechnol. 51:71-89).
A viable and stable formulation for intestinal targeting of probiotics has
been described by Simmonds et al. (2005). The process requires the
granulation of lyophilized bacteria with microcrystalline cellulose
stabilizers such as skim milk, salts or short chain sugars and a
disintegrant such as starch or alginic acid. The granulated semi dry
bacteria are then desiccated at 40-70.degree. C. to reduce the residual
moisture level to less than 2 percent. This is followed by coating with an
enteric agent and plasticizer. This multi-step process results in large
particle size (over 425 micron) and still results in up to 1.5 logs loss
of viability. An additional disadvantage of this method is the high
content of the enteric coating agents (over 25% of the microsphere
weight), which are mostly synthetic and not recognized as food grade
materials. An inherent disadvantage of a coating procedure is that the
relative proportion of the coating to active agent goes up by a cubic
function of the particle, as the particle size gets smaller, making the
process less usable for the production of particles of sizes less than 300
micron.
An alternative method of bacterial preservation has been described which
uses a foam formation technique while eliminating the formation of ice
crystals (Bronshtein et al. 2004, Roser et al. 2004). This method requires
high concentrations of sugars (a combination of methylated mono, di and
oligo saccharides) in the drying media and a freeze drier that is equipped
with a controlled vacuum system and temperature exposure, and the addition
of foam forming elements and stabilizers. In spite of some advantages of
this method in achieving longer shelf life stability, the foam-preserved
bacteria are not protected from gastric excursion. Furthermore this
process is difficult and costly to scale up because the foam requires, by
definition, large volumes of space under reduced atmospheric pressure
(i.e., in a vacuum) for the production of very little mass. In addition,
this material is very sensitive to humidity and the product will take up
water readily, decreasing the viability of the bacteria.
A composition containing a sugar (trehalose) partly in amorphous glassy
phase and partly in crystalline hydrate phase has been proposed by Franks
et al (2003). The crystalline hydrate phase serves as an agent to
dehydrate the amorphous phase, thereby enhancing the glass transition
temperature of the amorphous glassy state. This composition was shown to
stabilize single molecules such as proteins or nucleotides. The glass
transition temperature of a mixture depends, among other factors, on its
chemical composition (sugars, proteins, salts) and the moisture content,
with water acting as a plasticiser, depressing the glass temperature. If,
at any time, the glass transition temperature (Tg) is exceeded, either by
exposure to heat or in consequence of moisture migration into the product,
the amorphous glassy state may become liable to irreversible phase
separation by crystallization. If crystallization occurs, any residual
amorphous phase will then be composed of the other components and the
moisture, resulting in a further depression of the glass transition
temperature.
A glass is an amorphous solid state that is obtained by controlled
desiccation of a solution. The advantage of the glassy phase in achieving
long term stability results from the fact that diffusion in glassy
(vitrified) materials occurs at extremely low rates (e.g., microns/year).
Glassy materials normally appear as homogeneous, transparent, brittle
solids, which can be ground or milled into a powder. The optimal benefits
of vitrification for long-term storage are observed under conditions where
Tg is greater than the storage temperature. The Tg is directly dependent
on water activity and temperature, and may be modified by selecting an
appropriate combination of solutes (i.e., polysaccharides, sugars, salts
and proteins).
Glass formation occurs naturally in some plant and arthropod species that
are very desiccation tolerant. A number of mosses and ferns, so-called
resurrection plants, can undergo severe desiccation and survive for many
years in a quiescent metabolic state only to revive upon the return of
water to the environment. In most cases, the adaptation characteristic is
to increase internal concentrations of certain saccharides such as
trehalose to a level that form glassy states.
Prior to the current disclosure, no one has been able to provide a common
and cost effective solution to the separate problems facing the probiotic
industry, namely maintaining long shelf life stability (i.e., viability)
of bacterial cells at ambient temperatures and high water activities (or
high humidity) and providing gastric protection to minimize losses of
probiotic viability during the transit through the stomach. The present
invention overcomes these problems.
BRIEF SUMMARY OF THE DISCLOSURE
The present invention encompasses compositions and methods of producing
microparticles comprising a solid matrix in a glass form suitable for oral
delivery. The compositions include a combination of a polysaccharide, a
saccharide, a polyol and a probiotic bacteria. These compositions are
designed to provide longer shelf life stability at ambient temperature in
high water activity environments, and gastric protection of the probiotic.
Furthermore, the method of production of this matrix involves processes
that result in a minimal loss of probiotic viability.
Accordingly, one aspect of the invention comprises a preservation mixture
of carbohydrates including at least one polysaccharide, one saccharide
(mono di or oligo saccharide) and one polyol and at least one bacterium to
be incorporated in the carbohydrate mixture.
In a preferred aspect, the bacteria in the preservation carbohydrate
mixture are probiotic bacteria selected from, but not limited to the group
consisting live Lactobacillus, Bifidobacterium, Enterococcus,
Propionobacterium, Bacillus, and Streptococcus.
In another aspect of the invention the polysaccharide in the preservation
mixture provides gastric protection and control release mechanism that
gradually release the microbes at their site of action along the fore and
hind gut of the animal or man. Examples of polysaccharides with gastric
protection and a controlled release mechanism are hydrocolloid forming
polysaccharides selected from the group including, but not limited to
starch (including non-digestible starch), pectin, insulin, xanthan gum,
alginate, alginic acid, chitosan, carrageenan, carboxymethyl cellulose,
methyl cellulose, guar gum, gum arabic, locust bean gum and combinations
thereof. Also preferably, the concentration of the polysaccharides in the
preservation mixture is less than 10% w/v and more preferably less than 5%
w/v of the preservation mixture.
In another aspect of the invention the saccharide/polyol combination in
the preservation mixture is formulated so that it does not crystallize
during drying and long-term storage at ambient temperature. A suitable
glass formulation system includes, but is not limited to, trehalose/glycerol,
trehalose/mannitol, trehalose/maltitol, trehalose/isomalt, trehalose/adonitol,
trehalose/lactitol and trehalose/sorbitol. Trehalose is a naturally
occurring, non-reducing disaccharide, which is associated with the
prevention of desiccation damage in certain plants, microbes and animals
that can dry out without damage and revive when rehydrated. Trehalose also
has been shown to be useful in preventing denaturation of proteins,
viruses and foodstuffs during desiccation (Chen et al. 2001, Crowe and
Crowe 1992, Liao et al. 2002). Compared to sucrose, the glass transition
temperature of trehalose is significantly higher (110.degree. C. vs. only
65.degree. C.) (Crowe et al. 1998). However, trehalose alone is not always
sufficient to stabilize bacteria especially at high temperature and
humidity. In addition, cell membranes are more permeable to external sugar
alcohols than to external trehalose (Krallish I et al. 1997, Linders L J
et al. 1997, Qiu L et al. 2000). It is the synergetic effect of trehalose
and sugar alcohols that provide better protection and improve cell
viability over extended period of storage. Preferably, the concentration
of the both saccharide and polyol in the mixture is less than 60% w/v and
more preferably less than 40% w/v of the preservation mixture. The ratio
between the saccharide and the polyol is preferably about 3:1 trehalose/polyol,
although a ratio of 1:3 trehalose/polyol is also similarly effective in
the preservation of certain probiotic species.
The present invention also provides methods of drying the mixture in glass
form with a minimum loss of viability. It was discovered that vitrifying
and efficient drying of the preservation mixture under vacuum was possible
without the need of foam formation as described by Bronshtein (2004).
Gelling or cross-linking the polysaccharides in the preservation mixture
and slicing it to small pieces eliminated the need to foam the mixture in
order to dry it under vacuum. It also reduced the formation of a rubbery
product which happened often in the foaming process. Preferably, the
preservation mixture, including the probiotic, is allowed to gel at low
temperature and is then sliced and vacuum dried under conditions suitable
for glass formation. More preferably the polysaccharide in the mixture is
selected from the group of cross-linkable polysaccharides such as
alginate, pectin or chitosan. The mixture is then extruded into Ca.sup.++
bath and the strings or particles collected, rinsed with water, and then
soaked in a suitable trehalose/polyol mixture followed by vacuum drying
under conditions suitable for glass formation.
The present invention also provides methods of vacuum drying the
preservation matrix without foaming or ice formation. The glass formation
drying method comprises maintaining the matrix at 40.degree. C., applying
an initial vacuum of about 2,500 mTOR for a period of time followed by
drying at less than 100 mTOR for another period of time. The initial
product temperature is preferably maintained at or about 10-20.degree. C.
during the period at partially reduced pressure (2,500 mTOR) and then
increased to 40-50.degree. C., as the atmospheric pressure is decreased to
less than 100 mTOR. A final drying step at 20.degree. C. under maximum
vacuum (ca. 10 mTOR) for additional period of time can also be of benefit
for the final water removal. The dry matrix can then be ground or milled
and, if necessary, sieved to a desired particulate powder.
DETAILED DESCRIPTION
Fundamental to this invention is a polysaccharide capable of forming a
strong gel matrix. This matrix preferably retains the bacteria and the
preservation mixture even after being sliced into small pieces or formed
into thin threads, strings, or particles. Additionally, the polysaccharide
matrix preferably possesses a controlled release mechanism that protects
the bacteria in the stomach, but is able to release the bacteria at their
site of action along the intestine.
Several polysaccharides exhibit these requirements and are suitable for
use as described herein. High amylose starch is a polysaccharide capable
of forming firm gel after hydrating the starch granules in boiling water,
dispersing the granules with the aid of high shear mixer and then cooling
the solution to about 0-10.degree. C. The firmness and strength of the gel
depend on the concentration of the starch in the solution, with a maximal
workable concentration of up to 10% w/v. The sliced starch gel matrix is
also capable of retaining the live bacteria in the preservation mixture,
and since it is mostly non-digestible by intestinal or gastric juices, the
bacteria are protected from gastric destruction while within the starch
matrix. The controlled release mechanism is provided by the fact that high
amylose starch is readily digestible by the gut microflora at which time
the delivered live bacteria are then released in their intact form.
Pectin is another suitable polysaccharide that performs very similar to
high amylose starch. Pectin has an additional advantage since the strength
of the pectin gel matrix can be further increased by the addition of
divalent cations such as Ca.sup.++ that forms bridges between carboxyl
groups of the sugar polymers.
In a preferred embodiment of the present invention, alginate or a
combination of alginate and non-digestible starch is used. Alginate can
form a firm gel matrix by cross-linking with divalent cations. The
alginate containing preservation solution can be hardened into a firm gel
matrix by internally cross-linking the alginate polysaccharides with
Ca.sup.++ and then slicing the gel into small pieces while the bacteria
and the preservation mixture are fully retained within the gel matrix.
Another method of cross linking the solution containing alginate and
preservation mixture is by extruding thin threads or strings of the
solution into Ca.sup.++ bath. The strings harden instantly upon
interaction with Ca.sup.++. The thin strings are harvested, rinsed with
fresh water and then soaked again in the preservation solution but without
the presence of polysaccharides. Another suitable method is to inject the
thin threads into Ca.sup.++ bath, which also contains a preservation
mixture at equal concentration and proportion of that of the extruded
solution. An alternative method of preparation of the matrix is to spray
atomize the mixture into a bath containing Ca.sup.++ cations. In such a
procedure, small microparticles from 50 to 500 microns are produced. Such
particles are harvested, rinsed and soaked in the preservation medium, or
the bath itself may contain the preservation mixture as described above
for the production of thin threads or strings.
The level of Ca.sup.++ in the bath is constantly monitored and only
sufficient amount of cations necessary to cross link the alginate are
added at a time. This eliminates the need to rinse excessive Ca.sup.++
from the strings or particles, thereby retaining all the sugar in the
matrix, which would otherwise be washed away. In one preferred mode of the
present invention, monitoring the Ca.sup.++ cations within a range of
0.25-0.5% w/v in the cross-linking bath is sufficient to harden the
extruded alginate solution without any damage to the probiotic bacteria.
The gastric protection and controlled release trigger is also fulfilled by
the use of alginate polysaccharide. A polymeric matrix containing alginate
remains firm in the acidic environment of the stomach, thereby protecting
the bacteria, but quickly disintegrates in the higher pH and
phosphate-rich environment of the intestine. This results in the release
of the probiotic bacteria at their site of action along the intestine.
The purpose of the preservation mixture is to provide protection from
temperature and moisture excursions of the final product without undue
loss of viability of the probiotic bacteria. An ideal mixture contains a
combination of saccharides and sugar alcohols that form an amorphous
glassy phase with a glass transition temperature (Tg) well above ambient
temperature and water activity of the product. Trehalose alone is not
always sufficient to stabilize bacteria, especially at high temperature
and humidity. A more suitable mixture was found to be a combination of
trehalose and additional sugar alcohol that provides a synergetic effect
of better protection and improved cell viability over extended periods of
storage. In addition to sugar alcohols and other long chain polyalcohols,
other preservation agents include sucrose, lacto sucrose, raffinose,
maltodextrose, sepharose and dextran. These compounds may synergistically
improve the preservation of certain bacteria species.
The concentration and proportion of different carbohydrates in the
preservation mixture depends on several factors, but most particularly on
the bacteria species, strain, and drying conditions. The present invention
discloses several optimal concentrations and sugar proportions suitable
for inclusion in the preservation mixture for a number of probiotic
bacteria. Preferably, the carbohydrate concentration should be less than
about 50%, as higher concentrations may interfere with effective drying.
The preservation mixture optionally include other additives that
contribute to the overall stability of the probiotic bacteria. Suitable
additives include proteins, amino acids, diluents, chelating agents,
buffers, preservatives, stabilizers, antioxidants, and lubricants.
Specific examples of such additives would include, but are not limited to:
amino acids, lysine, glycine, L leucine, isoleucine, arginine, cysteine;
proteins, human serum proteins, egg albumin, gelatin; buffers, various
sodium phosphate buffers, citric/citrate buffers; preservatives,
derivatives of hydroxybenzoic acids; antioxidants, vitamin E, ascorbic
acid; lubricants, water miscible silicone/silicates; chelating agents,
citric acid, EDTA, EGTA.
In a preferred mode of the present invention, the sliced gel or thin
threads or strings are dried in such a way that a glass is formed. Several
drying methods can be employed, including, but not limited to, air drying
at ambient temperature, spray drying, fluidized bed drying, vacuum drying,
and freeze drying. As used herein, the glass containing the dried bacteria
cells preferably contains a residual moisture content of less than about
5%, and, more preferably, less than about 2%.
Drying is preferably performed under vacuum in a freeze drier at a product
temperature above the freezing temperature of water under such conditions.
In general, vacuum drying are performed in two stages. The first stage
involves moderately reduced pressure (ca. 2500 mTOR) at mild temperatures
(20.degree. C.), while the second stage involves lower pressures (i.e.,
higher vacuum -100 mTOR) at higher temperature (up to about 50.degree.
C.). This process can be achieved using a programmable control system for
vacuum pressure and product temperature. The vacuum and temperature
conditions for the first drying stage are adjusted empirically according
the size of the drier, heat transfer capacity, and the product load, but
the goal is to keep the product above its freezing temperature while
maximizing the water evaporation rate. In one embodiment, the temperature
is initially maintained at about 20.degree. C. for about 16 hours,
followed by gradually increasing the temperature to about 50.degree. C.
for the following 48 hours. These drying conditions allow the formation of
glassy state wherein the bacteria are locked in a quiescent state inside
the polysaccharide matrix.
In a preferred embodiment, the probiotic bacteria are dried as follows:
the initial vacuum pressure is adjusted to about 2500 mTOR, with initial
shelf temperature of 40.degree. C. for 12 hours, followed by incrementally
reducing the atmospheric pressure (i.e., increasing the vacuum) to less
than 100 mTOR at a rate of 125 mTOR/hr. Once the vacuum reaches 100 mTOR,
the sample is maintained at 40.degree. C. for an additional 12 hours.
Following this protocol, the drying procedure is completed within 48 hours
without substantially compromising viability. In accordance with the
present invention, the large surface area of the sliced and chopped gel or
strings greatly increases evaporation rate without the need to boil or
foam the product, thus eliminating inconsistent drying conditions and
splattering of the foaming product solution in the vacuum chamber.
Additionally, the disclosed composition and method of drying results in a
higher loading capacity of product as compared to the foam drying method,
that permits only a thin layer of solution to foam and dry efficiently.
An alternative drying procedure for the freshly prepared matrix strings or
particles includes a controlled desiccation of the matrix by addition of
the hydrogel to a certain volume (preferably 1:10 by weight) of dry
powdered saccharide such as trehalose or dry powdered preservation
mixture. During this process, the hydrogel is rapidly desiccated at
ambient temperature, concentrating the preservation material in the matrix
itself. The process is preferably set up in a counter-current fashion
where the fully hydrated hydrogel matrix containing the bacteria is added
to one end of the process stream and fresh, dry powdered preservation
saccharide flows from the opposite direction (FIG. 1 (see Original Patent)).
The wetted powdered saccharide material are dried at elevated temperature
and reused while the partially desiccated hydrogel then goes on to the
second stage of vacuum drying described above. This process significantly
reduces the drying time and process costs.
The resultant matrix-bound glass material containing the dried, stabilized
probiotic bacteria has a Tg sufficiently high to preserve the bacteria at
ambient temperature (up to 30.degree. C.) in a relative humidity of 33%.
Generally, the higher the Tg, the higher the allowable storage temperature
and humidity. Tg of the dry glassy preservation mixture of the present
invention is determined using standard techniques in the art, such as
differential scanning calorimetry.
The methods and compositions of the invention facilitate the development
of several products, including, but not limited to: live bacterial
vaccines in a dry stable form, live bacterial neutraceuticals (probiotics)
in a dry stable form, live bacterial starter cultures in a dry stable
form, live bacteria in a dry stable form for agricultural, aquaculture, or
bioremedial use, and live bacterial cultures in a dry stable form for the
biotechnology industry.
Claim 1 of 10 Claims
1. A process for producing a glass matrix
comprising a probiotic bacteria, the process comprising: a) dispersing
under heating conditions at least one polysaccharide in water; b) adding
trehalose, a sugar alcohol and a probiotic bacteria to the dispersed
polysaccharide to form a slurry, wherein the ratio of trehalose to sugar
alcohol is 3:1 to 1:3 and wherein the sugar alcohol is selected from a
group consisting of mannitol, glycerol, sorbitol, xylitol, maltitol,
lactitol and isomalt; c) contacting the slurry with a bath comprising
Ca.sup.++ ions for a sufficient time to allow cross-linking thereby
forming a gel matrix d) harvesting the gel matrix and placing the
harvested gel matrix in a drier wherein the temperature of the harvested
gel matrix is maintained above the freezing temperature of water; e)
reducing the pressure during a first drying stage and maintaining the
temperature at about 10-20.degree. C. for a first period of time; and f)
further reducing the pressure during a second drying stage and increasing
the temperature to between about 40-50.degree. C. for a second period of
time to produce the glass matrix comprising the probiotic bacteria. ____________________________________________
If you want to learn more
about this patent, please go directly to the U.S.
Patent and Trademark Office Web site to access the full
patent.
|